Hepion Pharmaceuticals (HEPA) Stock Chart & Stock Price History → Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (From InvestorPlace) (Ad) Free HEPA Stock Alerts $1.19 -0.07 (-5.56%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Hepion Pharmaceuticals Stock Price Performance5 Day Performance-9.85%1 Month Performance-45.66%3 Month Performance-39.90%6 Month Performance-59.25%Year-To-Date Performance-63.27%1 Year Performance-81.93% Receive HEPA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyAmerica could fall from this eventAmerica’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. HEPA Stock Chart for Tuesday, May, 14, 2024 HEPA Chart by TradingView Hepion Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$1.26$1.19-5.56%$1.26$1.1835,436 shs$6.51 million05/10/2024$1.32$1.26-4.55%$1.38$1.1989,446 shs$6.89 million05/09/2024$1.31$1.32+0.76%$1.40$1.3015,060 shs$7.22 million05/08/2024$1.37$1.31-4.38%$1.55$1.3077,695 shs$7.17 million05/07/2024$1.38$1.37-0.72%$1.44$1.3012,853 shs$7.49 million05/06/2024$1.46$1.38-5.48%$1.54$1.3834,402 shs$7.55 million Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$1.52$1.46-3.95%$1.59$1.4632,548 shs$7.99 million05/02/2024$1.36$1.52+11.76%$1.55$1.3741,718 shs$8.31 million05/01/2024$1.37$1.36-0.37%$1.40$1.346,132 shs$7.44 million04/30/2024$1.38$1.37-1.09%$1.41$1.339,096 shs$7.47 million04/29/2024$1.37$1.38+0.73%$1.44$1.3420,232 shs$7.55 million04/26/2024$1.29$1.37+6.20%$1.44$1.2739,627 shs$7.49 million04/25/2024$1.32$1.29-2.27%$1.35$1.2722,992 shs$7.06 million04/24/2024$1.49$1.32-11.41%$1.54$1.3037,310 shs$7.22 million04/23/2024$1.41$1.49+5.67%$1.52$1.2970,728 shs$8.15 million04/22/2024$2.01$1.41-29.85%$1.60$1.22321,558 shs$7.71 million04/19/2024$2.05$2.10+2.44%$2.20$2.05131,814 shs$11.49 million04/18/2024$2.04$2.05+0.49%$2.21$2.0427,949 shs$8.90 million04/17/2024$2.04$2.04$2.21$2.0021,541 shs$8.85 million04/16/2024$2.18$2.04-6.42%$2.22$2.0425,712 shs$8.85 million04/15/2024$2.19$2.18-0.46%$2.35$2.1610,027 shs$9.46 million04/12/2024$2.27$2.19-3.52%$2.30$2.1816,941 shs$9.50 million04/11/2024$2.33$2.27-2.58%$2.35$2.0834,460 shs$9.85 million04/10/2024$2.44$2.33-4.51%$2.46$2.2535,130 shs$10.11 million04/09/2024$2.56$2.44-4.69%$2.56$2.3817,724 shs$10.59 million04/08/2024$2.52$2.56+1.59%$2.61$2.4716,226 shs$11.11 million04/05/2024$2.64$2.52-4.55%$2.64$2.4929,976 shs$10.94 million04/04/2024$2.56$2.64+3.13%$2.90$2.41122,307 shs$11.46 million04/03/2024$2.29$2.56+11.79%$2.56$2.2545,510 shs$11.11 million04/02/2024$2.36$2.29-2.97%$2.39$2.2226,580 shs$9.94 million04/01/2024$2.49$2.36-5.22%$2.45$2.3139,470 shs$10.24 million03/29/2024$2.49$2.49$2.53$2.4221,291 shs$10.81 million03/28/2024$2.50$2.49-0.40%$2.53$2.4221,288 shs$10.81 million03/27/2024$2.32$2.50+7.76%$2.56$2.2251,656 shs$10.85 million03/26/2024$2.28$2.32+1.75%$2.41$2.2532,817 shs$10.07 million03/25/2024$2.35$2.28-2.98%$2.37$2.218,445 shs$9.90 million03/22/2024$2.32$2.35+1.29%$2.42$2.0525,899 shs$10.20 million03/21/2024$2.34$2.32-0.85%$2.33$2.2014,562 shs$10.07 million03/20/2024$2.13$2.34+9.86%$2.35$2.0512,441 shs$10.16 million03/19/2024$2.18$2.13-2.29%$2.29$2.0724,604 shs$9.24 millionCrypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos…03/18/2024$2.26$2.18-3.54%$2.21$2.0745,771 shs$9.46 million03/15/2024$2.03$2.26+11.33%$2.36$1.9640,719 shs$9.81 million03/14/2024$2.09$2.03-2.87%$2.31$1.8950,387 shs$8.81 million03/13/2024$2.18$2.09-4.13%$2.44$2.0274,556 shs$9.07 million03/12/2024$2.24$2.18-2.68%$2.24$2.0828,722 shs$9.46 million03/11/2024$2.35$2.24-4.68%$2.38$2.1525,323 shs$9.72 million03/08/2024$2.27$2.37+4.41%$2.55$2.2645,603 shs$10.29 million03/07/2024$2.29$2.27-0.87%$2.43$2.2328,252 shs$9.85 million03/06/2024$2.60$2.29-11.92%$2.68$2.16107,042 shs$9.94 million03/05/2024$2.83$2.60-8.13%$2.93$2.5260,869 shs$11.28 million03/04/2024$3.17$2.83-10.73%$3.18$2.8350,155 shs$12.28 million03/01/2024$2.97$3.17+6.73%$3.33$3.0092,556 shs$13.76 million02/29/2024$2.75$2.97+8.00%$3.07$2.7970,898 shs$12.89 million02/28/2024$2.39$2.75+15.06%$2.82$2.34105,463 shs$11.94 million02/27/2024$2.33$2.39+2.58%$2.48$2.3057,342 shs$10.37 million02/26/2024$2.42$2.33-3.72%$2.59$2.2645,200 shs$10.11 million02/23/2024$2.45$2.42-1.22%$2.59$2.3099,946 shs$10.50 million02/22/2024$2.26$2.45+8.41%$2.60$2.1775,227 shs$10.63 million02/21/2024$2.48$2.26-8.87%$2.47$2.0753,875 shs$9.81 million02/20/2024$2.56$2.48-3.13%$3.05$2.3354,695 shs$10.76 million02/19/2024$2.56$2.56$3.49$2.04427,100 shs$11.11 million02/16/2024$2.68$2.56-4.48%$3.49$2.04427,128 shs$11.11 million02/15/2024$1.98$2.68+35.35%$2.95$1.93622,540 shs$11.63 million02/14/2024$1.82$1.98+8.79%$2.07$1.82142,550 shs$8.59 million02/13/2024$1.52$1.82+19.74%$2.27$1.53470,501 shs$7.90 million Related Companies: EFTR Stock Price Chart UPC Stock Price Chart VCNX Stock Price Chart KTTA Stock Price Chart CANF Stock Price Chart CYCN Stock Price Chart BNOX Stock Price Chart PCSA Stock Price Chart RNAZ Stock Price Chart VIRI Stock Price Chart Receive HEPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HEPA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsNo experience to confident trader, meet my student…Wealth Builders InstituteCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOIC Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.